2.0
2 May 2013
Anonymous employee
Current employee
Recommend
CEO approval
Business outlook
Pros
Strong financial management and great product performance TODAY
Cons
lack of developmental opportunites Too much exposure to HUMIRA \ Can we get anything to lauch out of our pipeline? Conflicing directions -- be a lean, decisive biopharmaceutical company and yet we just signed a CIA